Live Interview
And why does that matter?
This is how a Mato agent talks. Take the other seat: answer a few and feel it follow the thread.
Podcast charts
Published by The GOG Foundation, Inc.
Welcome to the official podcast of The GOG Foundation, Inc.—a nonprofit organization dedicated to advancing excellence in clinical and scientific research for gynecologic cancers. From ovarian and uterine to cervical, vaginal, and vulvar malignancies, our investigators and institutions are at the forefront of innovation, shaping the future of cancer care. Each episode features leading experts, groundbreaking trial insights, and real-world stories that illuminate the evolving landscape of gynecologic oncology. Whether you're a clinician, researcher, patient advocate, or survivor, join us as we explore the science, the people, and the progress driving better outcomes and quality of life for patients everywhere.
On the charts
Every published chart this podcast appears in, in the snapshot behind this page. Each one links to the chart it came off.
From the feed
The latest episodes published to this podcast’s own RSS feed. Titles and descriptions are the publisher’s.
The GOG Foundation, Inc. would like to thank our commercial supporters for their support of the GOG GYN-LIVE Podcast: Corcept Therapeutics, GSK, Pfizer Oncology, Eli Lilly, Genmab, and Verastem ★ Support this podcast ★
In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as second‑ or third‑line therapy for patients with recurrent or metastatic cervical cancer. ★ Support this podcast ★
The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel” , an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year. The GOG Highlight Reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course examines recent clinical trial data in gynecologic malignancies, offering insights on data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians in comprehending the evolving treatment landscape, including understanding trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions will focus on emerging approved therapies and investigational agents, with an intent to provide insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the skills to navigate the latest oncology research and clinical care confidently. The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: GSK, Merck, AbbVie, AstraZeneca, Corcept Therapeutics, Verastem, Eisai, Natera, Karyopharm Therapeutics, BioNTech The GOG Foundation, Inc. would also like to thank our sponsors for this symposium: Gilead, Faeth Therapeutics ★ Support this podcast ★
The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key components for developing successful clinical trials. Our expert leaders will share their knowledge, experience, and best practices to integrate into your clinical trial process. ★ Support this podcast ★
The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel” , an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year. A twice-yearly event, our most recent program took place Saturday, January 18, 2025, in Phoenix, Arizona alongside the 2025 NRG Oncology Winter Meeting. The GOG Highlight reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course takes a deep dive into clinical trials for gynecologic malignancies, offering insights on recent data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians to comprehend the evolving treatment landscape, including understanding available trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions analyze emerging approved therapies and investigational agents, providing insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the analytical skills to navigate the latest oncology research and clinical care confidently. The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: AbbVie, Acrivon Therapeutics, AstraZeneca, Corcept Therapeutics, GSK, and Eisai. The GOG Foundation, Inc., would also like to thank our sponsors for this symposium: Pfizer/Genmab and GSK. ★ Support this podcast ★
The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel” , an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year. This twice-yearly event was most recently held on Saturday, July 26, 2025, in Washington D.C. alongside the 2025 NRG Oncology Summer Meeting. The GOG Highlight Reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course takes a deep dive into clinical trials for gynecologic malignancies, offering insights on recent data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians to comprehend the evolving treatment landscape, including understanding available trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions analyze emerging approved therapies and investigational agents, providing insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the analytical skills to navigate the latest oncology research and clinical care confidently. The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: AbbVie, Acrivon, AstraZeneca, Corcept Therapeutics, Genelux, Gilead, GSK and Karyopharm The GOG Foundation, Inc. would also like to thank our sponsors for this symposium: Pfizer Oncology | Genmab, GSK, and Verastem ★ Support this podcast ★
The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key components for developing successful clinical trials. Our expert leaders will share their knowledge, experience, and best practices to integrate into your clinical trial process. ★ Support this podcast ★
Ranking source
Apple Podcasts rankings via the Mato Topic Intelligence Platform.
Observed September 20, 2026.
Apple and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.
Pairs with
Bring this source into Mato to read its transferable patterns, then turn them into an original show for your own audience.